Evidence map›Paper›PMID 27919744›Full record

ReviewParasitology international2017

Co-infections with liver fluke and Helicobacter species: A paradigm change in pathogenesis of opisthorchiasis and cholangiocarcinoma?

Banchob Sripa, Raksawan Deenonpoe, Paul J Brindley

Open access · greenAbstract readReview
In one paragraph

Review in Parasitology international, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Inflammatory responses toOpen veterinary journal · 2024
    Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Adherence ofParasitology · 2022
    Article
  14. Biliary Migration, Colonization, and Pathogenesis ofPathogens (Basel, Switzerland) · 2021
    Article
  15. Article
  16. Infection withPathogens (Basel, Switzerland) · 2020
    Article
  17. Review
  18. Microbes and Cancer: Friends or Faux?International journal of molecular sciences · 2020
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Banchob SripaWHO Collaborating Centre for Research and Control of Opisthorchiasis (Southeast Asian Liver Fluke Disease), Tropical Disease Research Center, Department of Pathology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand. Electronic address: banchob@kku.ac.th.
Raksawan DeenonpoeWHO Collaborating Centre for Research and Control of Opisthorchiasis (Southeast Asian Liver Fluke Disease), Tropical Disease Research Center, Department of Pathology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand; Chulabhorn International College of Medicine, Thammasat University, Pathum Thani 12120, Thailand.
Paul J BrindleyDepartment of Microbiology, Immunology and Tropical Medicine, Research Center for Neglected Tropical Diseases of Poverty, School of Medicine & Health Sciences, The George Washington University, Washington, DC 20037, USA.
George Washington University · USKhon Kaen University · THThammasat University · TH

Funding

Targeting parasite-host communication to combat liver fluke-induced bile duct cancerR01CA164719 · NCI · GEORGE WASHINGTON UNIVERSITY · PI Paul J Brindley, THEWARACH LAHA · 2012 to 2026
$5.0M
Pathogenesis of Opisthorchiasis induced persistent periductal fibrosis and CCAP50AI098639 · NIAID · KHON KAEN UNIVERSITY · PI SRIPA, BANCHOB · 2012 to 2016
$1.6M
NCI NIH HHS R01 CA164719NIAID NIH HHS P50 AI098639
6 · The paper itself

Abstract

Infection with the fish-borne liver fluke Opisthorchis viverrini is classified by the International Agency for Research on Cancer as a Group 1 carcinogen: definitely carcinogenic in humans. Cofactors likely contribute to bile duct cancer (cholangiocarcinoma) caused by this infection. Here we review recent findings that address the role of liver fluke associated H. pylori in hepatobiliary disease and malignancy. We hypothesize that co-infection by O. viverrini and the bacillus Helicobacter pylori is central of liver fluke infection associated cholangiocarcinoma.

Indexed as

AnimalsBile Duct NeoplasmsCholangiocarcinomaCoinfectionDisease ReservoirsHelicobacter InfectionsHelicobacter pyloriHumansOpisthorchiasisOpisthorchisCholangiocarcinomaCo-infectionHelicobacter spp.Hepatobiliary diseasesLiver flukeOpisthorchis viverriniPathogenesis

Identifiers

PMID27919744
PMCPMC5457716
OpenAlexW2559276772

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.